Published in Clin Exp Immunol on January 01, 2006
High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls. Mol Med (2011) 1.19
Traffic-related particulate matter and acute respiratory symptoms among New York City area adolescents. Environ Health Perspect (2010) 1.02
Markers of respiratory inflammation in horses in relation to seasonal changes in air quality in a conventional racing stable. Can J Vet Res (2008) 0.88
Increased heat shock protein 70 levels in induced sputum and plasma correlate with severity of asthma patients. Cell Stress Chaperones (2011) 0.84
The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today (1996) 12.12
Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med (1992) 11.90
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med (1997) 10.67
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet (2002) 8.57
Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med (2000) 5.82
Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med (1999) 4.75
Interleukin-6 family of cytokines and gp130. Blood (1995) 4.52
Non-eosinophilic asthma: importance and possible mechanisms. Thorax (2002) 3.53
Non-eosinophilic corticosteroid unresponsive asthma. Lancet (1999) 3.25
IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med (1996) 1.93
Induced sputum cell counts in healthy adults. Am J Respir Crit Care Med (2000) 1.93
Tumour necrosis factor-alpha: the role of this multifunctional cytokine in asthma. Immunol Cell Biol (2001) 1.73
Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product. J Immunol (1995) 1.42
Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers. Eur Respir J (1999) 1.42
Induced sputum cellularity. Reference values and distribution in normal volunteers. Am J Respir Crit Care Med (2000) 1.40
Circulating interleukin-6 levels in patients with bronchial asthma. Am J Respir Crit Care Med (1995) 1.34
Immunolocalization of interleukin-4 in eosinophils in the bronchial mucosa of atopic asthmatics. Am J Respir Cell Mol Biol (1996) 1.07
Local expression of epsilon germline gene transcripts and RNA for the epsilon heavy chain of IgE in the bronchial mucosa in atopic and nonatopic asthma. J Allergy Clin Immunol (2001) 1.05
Cytokine production from sputum cells after allergenic challenge in IgE-mediated asthma. Allergy (2002) 1.02
Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA) Clin Exp Immunol (1995) 1.00
The importance of Th2-like cells in the pathogenesis of airway allergic inflammation. Clin Exp Allergy (1993) 0.97
Chemokine production by the BEAS-2B human bronchial epithelial cells: differential regulation of eotaxin, IL-8, and RANTES by TH2- and TH1-derived cytokines. J Allergy Clin Immunol (2000) 0.96
Nebulised salbutamol administered during sputum induction improves bronchoprotection in patients with asthma. Thorax (2004) 0.95
Interleukin-4 and its receptor: essential mediators of the allergic response. J Allergy Clin Immunol (1997) 0.95
Lack of association between adult asthma and the tumour necrosis factor alpha-308 polymorphism gene. Eur Respir J (2000) 0.87
Interleukin-4 as a potent down-regulator for human alveolar macrophages capable of producing tumour necrosis factor-alpha and interleukin-1. Eur Respir J (1992) 0.87
The anti-inflammatory effects of interleukin-10 in allergic disease. Clin Exp Allergy (2000) 0.85
TH2-type cytokines in asthma. Ann N Y Acad Sci (1996) 0.85
Cytokine production from peripheral whole blood in atopic and nonatopic asthmatics: relationship with blood and sputum eosinophilia and serum IgE levels. Allergy (2000) 0.84
Cell infiltration, ICAM-1 expression, and eosinophil chemotactic activity in asthmatic sputum. Am J Respir Crit Care Med (1997) 0.82
Is there more than one inflammatory phenotype in asthma? Thorax (2002) 0.81
Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol (1998) 2.20
Association between asthma control and bronchial hyperresponsiveness and airways inflammation: a cross-sectional study in daily practice. Clin Exp Allergy (2009) 1.51
Exhaled nitric oxide as a marker of asthma control in smoking patients. Eur Respir J (2009) 1.44
[COPD and inflammation: statement from a French expert group: inflammation and remodelling mechanisms]. Rev Mal Respir (2010) 1.40
Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation. Eur Respir J Suppl (2002) 1.36
MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol (2000) 1.33
"Real-life" effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study. Respir Med (2009) 1.32
Fusion of the lumbar and sacral spine by internal fixation with screw plates. Clin Orthop Relat Res (1986) 1.20
Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma. Eur Respir J (2009) 1.12
Clinical applications of assessment of airway inflammation using induced sputum. Eur Respir J Suppl (2002) 1.10
Cytokine production from sputum cells after allergenic challenge in IgE-mediated asthma. Allergy (2002) 1.02
Local and systemic cellular inflammation and cytokine release in chronic obstructive pulmonary disease. Cytokine (2011) 1.00
[Unstable fractures of the spine. III.Instability. A. Theories concerning instability]. Rev Chir Orthop Reparatrice Appar Mot (1978) 0.99
Matrix metalloproteinases and TIMP-1 production by peripheral blood granulocytes from COPD patients and asthmatics. Allergy (2001) 0.99
Pathogenic role of matrix metalloproteases and their inhibitors in asthma and chronic obstructive pulmonary disease and therapeutic relevance of matrix metalloproteases inhibitors. Cell Mol Biol (Noisy-le-grand) (2003) 0.98
Increased frequency of bronchial hyperresponsiveness in patients with inflammatory bowel disease. Allergy (1995) 0.98
Spinal stability as defined by the three-column spine concept. Anat Clin (1985) 0.98
Nebulised salbutamol administered during sputum induction improves bronchoprotection in patients with asthma. Thorax (2004) 0.95
Is the neutrophil a worthy target in severe asthma and chronic obstructive pulmonary disease? Clin Exp Allergy (2006) 0.94
Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease. Eur Respir J (2002) 0.92
Bronchial responsiveness in active steelworkers. Eur Respir J (1998) 0.92
Induced sputum: comparison between isotonic and hypertonic saline solution inhalation in patients with asthma. Chest (2001) 0.91
IFN-γ and TNF-α potentiate prostaglandin D2-induced human eosinophil chemotaxis through up-regulation of CRTH2 surface receptor. Int Immunopharmacol (2011) 0.90
The triple neurokinin-receptor antagonist CS-003 inhibits neurokinin A-induced bronchoconstriction in patients with asthma. Pulm Pharmacol Ther (2005) 0.87
[Lung cancer. Epidemiology and etiologic factors]. Rev Med Liege (2007) 0.86
Update on the roles of distal airways in asthma. Eur Respir Rev (2009) 0.85
The impact of concomitant rhinitis on asthma-related quality of life and asthma control. Allergy (2010) 0.85
Sputum eosinophil count in a large population of patients with mild to moderate steroid-naive asthma: distribution and relationship with methacholine bronchial hyperresponsiveness. Allergy (2002) 0.85
Cytokine production from peripheral whole blood in atopic and nonatopic asthmatics: relationship with blood and sputum eosinophilia and serum IgE levels. Allergy (2000) 0.84
Bronchial eosinophilic infiltration in Crohn's disease in the absence of pulmonary disease. Clin Exp Allergy (1999) 0.83
Beyond corticosteroids: future prospects in the management of inflammation in COPD. Eur Respir Rev (2011) 0.83
[Cervical sprains and cervical herniated discs (author's transl)]. Nouv Presse Med (1979) 0.82
[Therapeutic indications in unstable fractures of the spine]. Rev Chir Orthop Reparatrice Appar Mot (1978) 0.82
Dual tachykinin NK1/NK2 antagonist DNK333 inhibits neurokinin A-induced bronchoconstriction in asthma patients. Eur Respir J (2004) 0.81
Blood mononuclear cells mobilization and cytokines secretion during prolonged exercises. Int J Sports Med (1996) 0.81
Perception of dyspnea in mild smoking asthmatics. Respir Med (2007) 0.81
On-line monitoring of multiple precordial leads in high risk patients with coronary artery disease--a pilot study. Eur Heart J (1984) 0.81
[Clinical case of the month. Idiopathic mediastinal fibrosis]. Rev Med Liege (2013) 0.81
[Paroxysmal dyspnoea in a healthy individual: the spontaneous pneumothorax]. Rev Med Liege (2004) 0.80
[Eotaxin: an important chemokine in asthma]. Rev Med Liege (2006) 0.80
Induced sputum in asthma: from bench to bedside. Curr Med Chem (2011) 0.80
[Recent injuries of the lower cervical spine]. Rev Chir Orthop Reparatrice Appar Mot (1984) 0.80
Differences in local versus systemic TNFalpha production in COPD: inhibitory effect of hyaluronan on LPS induced blood cell TNFalpha release. Thorax (2006) 0.80
Lung function and airway inflammation monitoring after hematopoietic stem cell transplantation. Respir Med (2013) 0.80
[Pathological fracture of the femoral neck and fibrous dysplasia of bone]. Bull Soc Med Afr Noire Lang Fr (1967) 0.79
[Ventral approach to the cervical spine]. Orthopade (1987) 0.79
Neurotensin may function as a regulatory peptide in small cell lung cancer. Peptides (1991) 0.78
[Atloido-axoid surgery by a transoral approach]. Rev Chir Orthop Reparatrice Appar Mot (1983) 0.78
[Surgery of Pott's disease with correction of the gibbosity]. J Chir (Paris) (1970) 0.78
Airway mast-cell activation in asthmatics is associated with selective sputum eosinophilia. Allergy (1999) 0.78
Cytokine production from sputum cells and blood leukocytes in asthmatics according to disease severity. Allergy (2010) 0.78
[Radioanatomy of the cavernous sinus]. Neurochirurgie (1972) 0.78
[The UPLIFT study (Understanding Potential Long-term Impacts on Function with Tiotropium)]. Rev Med Liege (2009) 0.78
Contribution of positron emission tomography in pleural disease. Rev Mal Respir (2010) 0.78
Is FENO50 useful diagnostic tool in suspected asthma? Int J Clin Pract (2012) 0.78
[Voluminous osteochondroma of the knee cap. Patellectomy]. Bull Soc Med Afr Noire Lang Fr (1968) 0.78
[Controlled orthopedic reduction of spinal fractures]. Rev Chir Orthop Reparatrice Appar Mot (1975) 0.78
[Clinical study of the month: the TORCH study (TOwards a Revolution in COPD Health)]. Rev Med Liege (2007) 0.77
[Inertia and adherence as factors influencing asthma control]. Rev Med Liege (2010) 0.77
[COPD and inflammation: statement from a French expert group. Phenotypes related to inflammation]. Rev Mal Respir (2011) 0.77
[Targeted asthma therapies: confirmations, hopes, and disappointments]. Rev Med Liege (2012) 0.77
Organ specificity of induction of activating and inactivating enzymes by cigarette smoke and cigarette smoke condensate. Arch Toxicol Suppl (1979) 0.77
[Asthma and tobacco]. Rev Med Liege (2006) 0.77
2B4 (CD244) is involved in eosinophil adhesion and chemotaxis, and its surface expression is increased in allergic rhinitis after challenge. Int J Immunopathol Pharmacol (2012) 0.77
Anti-IgE: a significant breakthrough in the treatment of airway allergic diseases. Allergy (2004) 0.77
[MANAGEMENT OF NON-SMALL CELL LUNG CANCER]. Rev Med Liege (2015) 0.77
[Topographic study of the inferior vena cava in West Africans]. Bull Soc Med Afr Noire Lang Fr (1971) 0.76
[The azygos or vertebro-parietal venous anastomotic system]. Bull Assoc Anat (Nancy) (1976) 0.76
Development of recombinant stable house dust mite allergen Der p 3 molecules for component-resolved diagnosis and specific immunotherapy. Clin Exp Allergy (2015) 0.76
Effect of a 4-week treatment with theophylline on sputum eosinophilia and sputum eosinophil chemotactic activity in steroid-naive asthmatics. Clin Exp Allergy (2000) 0.76
[Asthma-COPD overlap syndrome among patients with stable COPD]. Rev Med Liege (2015) 0.76
Health status instrument vs. prognostic instrument for assessing chronic obstructive pulmonary disease in clinical practice. Int J Clin Pract (2010) 0.76
[Stable arthrodesis of the lumbosacral region]. Rev Chir Orthop Reparatrice Appar Mot (1976) 0.76
[Comparison between chylothorax and pseudochylothorax]. Rev Med Liege (2015) 0.76
Plasma histamine and bronchial reactivity in allergic asthma. Allergy (1993) 0.76
Cysteinyl-leukotrienes contribute to sputum eosinophil chemotactic activity in asthmatics. Allergy (2006) 0.76
[Bronchial morphologic modification in asthma]. Rev Med Liege (2000) 0.76
Induced sputum: not only for research but also for better patient management in asthma and COPD. Monaldi Arch Chest Dis (2012) 0.75
Increased response of blood eosinophils to various chemotactic agents in quiescent Crohn disease. Scand J Gastroenterol (2001) 0.75
Radiation exposure of very low birth weight (< 1500-g) infants. Pediatrics (1997) 0.75
Anatomo-radiological considerations about lumbar discography. An experimental study. Neuroradiology (1979) 0.75
[Unstable fractures of the spine. IV. Stabilization methods and their results. A. Nonsurgical methods. 3. Orthopedic reduction]. Rev Chir Orthop Reparatrice Appar Mot (1978) 0.75